Opthea To Present at Upcoming Investor Conferences
May 11, 2022 08:00 ET
|
Opthea Limited
MELBOURNE, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive...
Opthea Presentation at The Retina World Congress 2022
May 10, 2022 08:20 ET
|
Opthea Limited
MELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...